Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2020 · 10-Q
Revenue$7.73B$7.73B+2.5% vs Q1 2019 Net Income$564.00M$564.00M−16.1% vs Q1 2019 EPS Diluted$0.31$0.31−18.4% vs Q1 2019 Operating Income$758,000,000+2.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Free Cash Flowderived$355,000,000−5.8% Margins · derivedOperating margin9.8%+0.0 pt vs Q1 2019
Net margin7.3%−1.6 pt vs Q1 2019
ended Mar 31, 2020 · filed Apr 29, 2020 · 29 d after period end